0001185185-23-000124.txt : 20230214 0001185185-23-000124.hdr.sgml : 20230214 20230214081802 ACCESSION NUMBER: 0001185185-23-000124 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230214 DATE AS OF CHANGE: 20230214 EFFECTIVENESS DATE: 20230214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: America Great Health CENTRAL INDEX KEY: 0001098009 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980178621 STATE OF INCORPORATION: CA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-27873 FILM NUMBER: 23622754 BUSINESS ADDRESS: STREET 1: 1609 W VALLEY BLVD UNIT 338A CITY: ALHAMBRA STATE: CA ZIP: 91803 BUSINESS PHONE: (888) 988-1333 MAIL ADDRESS: STREET 1: 1609 W VALLEY BLVD UNIT 338A CITY: ALHAMBRA STATE: CA ZIP: 91803 FORMER COMPANY: FORMER CONFORMED NAME: CROWN MARKETING DATE OF NAME CHANGE: 20111006 FORMER COMPANY: FORMER CONFORMED NAME: SPACE LAUNCHES FINANCING INC DATE OF NAME CHANGE: 19991028 NT 10-Q 1 amgreat20230213_nt10q.htm FORM NT 10-Q amgreat20230213_nt10q.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 12b-25

 

 

NOTIFICATION OF LATE FILING

 

☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-CEN ☐ Form N-CSR

 

For the Period Ended: December 31, 2022

 

☐ Transition Report on Form 10-K

☐ Transition Report on Form 20-F

☐ Transition Report on Form 11-K

☐ Transition Report on Form 10-Q

 

For the Transition Period Ended:                                              

 

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:                                                 

 

 

 
 

 

PART I - COMPANY INFORMATION

 

America Great Health

  

Full Name of Registrant

  
   
   

Former Name if Applicable

  
   

1609 W. Valley Blvd., #338

  

Address of Principal Executive Office (Street and Number)

  
   

Alhambra, CA 91803

  

City, State and Zip Code

  

 

PART II - RULES 12b-25 (b) and (c)

 

If the subject report could not be filed without reasonable effort or expense and the Company seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 

☒

(a)

The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     

☒

(b)

The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
     

☐

(c)

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable

 

PART III - NARRATIVE

 

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

The Company has not been able to compile the requisite financial data and other narrative information necessary to enable it to complete the Company’s Quarterly Report on Form 10-Q by February 14, 2023 without unreasonable effort and expense. 

 

 
 

 

PART IV - OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification:

 

Mike Wang

(888)

988-1333

(Name)

(Area code)

(Telephone Number)

 

(2) Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company act of 1940 during the preceding 12 months or for such shorter period that the Company was required to file such report(s) been filed? If the answer is no, identify report(s).     ☒ Yes   ☐ No

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?    ☐ Yes    ☒ No

 

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

  America Great Health

Date: February 14, 2023

 
 

By:  /s/Mike Wang

  
 

Mike Wang
 

President/CEO